Cure My Disease

Don't miss your cure!

 Log in / Sign up

Personalized nursing care may boost diabetes Self-Management

NCT ID NCT07808255

Disease control Sponsor: University of Yalova Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This trial tests whether individualized nursing care can help adults with diabetes feel more confident and capable in managing their condition. Participants receive structured, personalized sessions that include education, goal-setting, and self-monitoring guidance. The study measures changes in diabetes knowledge, self-management behaviors, and empowerment over three months. If successful, this approach could improve daily diabetes care and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Individualized nursing care sessions, including targeted education, goal-setting, self-monitoring guidance, and follow-up
What this could lead to
If effective, this approach could become a standard part of diabetes care, helping people manage their condition better and improve their quality of life.
What could go wrong
This is a small trial with 68 participants, so results may not apply broadly. The outcome depends on how well the nursing sessions are delivered and whether participants stay engaged.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 68 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with diabetes (Type 1 or Type 2) * Age 18 years or older * Able to communicate in Turkish and cooperate with the study requirements * Voluntarily willing to participate and sign the informed consent form Exclusion Criteria: * Having severe cognitive impairment, psychiatric disorders, or communication barriers that prevent participation * Having severe terminal illnesses or acute medical complications that interfere with follow-up

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus Empowerment

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes mellitus Nursing care Self-care

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Yalova Training and Research Hospital

    Yalova, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.